Plumbline Life Sciences Statistics
Total Valuation
XKON:222670 has a market cap or net worth of KRW 28.59 billion.
Market Cap | 28.59B |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
XKON:222670 has 3.67 million shares outstanding.
Current Share Class | 3.67M |
Shares Outstanding | 3.67M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 23.76% |
Owned by Institutions (%) | 0.38% |
Float | 2.20M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 28.70 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.42, with a Debt / Equity ratio of 1.10.
Current Ratio | 0.42 |
Quick Ratio | 0.37 |
Debt / Equity | 1.10 |
Debt / EBITDA | n/a |
Debt / FCF | -3.25 |
Interest Coverage | -14.02 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -29.61% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.24% in the last 52 weeks. The beta is 0.44, so XKON:222670's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | +53.24% |
50-Day Moving Average | 7,298.80 |
200-Day Moving Average | 5,686.65 |
Relative Strength Index (RSI) | 56.96 |
Average Volume (20 Days) | 4,771 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -590.62M |
Pretax Income | -773.99M |
Net Income | -773.99M |
EBITDA | -348.84M |
EBIT | -590.62M |
Earnings Per Share (EPS) | -771.00 |
Balance Sheet
The company has 435.61 million in cash and 1.10 billion in debt, giving a net cash position of -663.59 million or -181.04 per share.
Cash & Cash Equivalents | 435.61M |
Total Debt | 1.10B |
Net Cash | -663.59M |
Net Cash Per Share | -181.04 |
Equity (Book Value) | 996.08M |
Book Value Per Share | 992.23 |
Working Capital | -674.57M |
Cash Flow
In the last 12 months, operating cash flow was -336.10 million and capital expenditures -2.50 million, giving a free cash flow of -338.61 million.
Operating Cash Flow | -336.10M |
Capital Expenditures | -2.50M |
Free Cash Flow | -338.61M |
FCF Per Share | -92.38 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
XKON:222670 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -2.71% |
FCF Yield | -1.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |